Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38α MAPK during insulin resistance.
about
The Role of p38 MAPK in the Development of Diabetic CardiomyopathyAdiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failureEndocrine and other physiologic modulators of perinatal cardiomyocyte endowmentAsparaginase treatment side-effects may be due to genes with homopolymeric Asn codons (Review-Hypothesis)The therapy of insulin resistance in other diseases besides type 2 diabetesReduced up-regulation of the nitric oxide pathway and impaired endothelial and smooth muscle functions in the female type 2 diabetic goto-kakizaki rat heartp38 MAP kinases in the heartInsulin Signaling and Heart Failure.Zinc rescues obesity-induced cardiac hypertrophy via stimulating metallothionein to suppress oxidative stress-activated BCL10/CARD9/p38 MAPK pathway.Viability of primary cultured podocytes is associated with extracellular high glucose-dependent autophagy downregulation.Decoding insulin resistance and metabolic syndrome for promising therapeutic intervention.Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.Mild Type 2 Diabetes Mellitus Reduces the Susceptibility of the Heart to Ischemia/Reperfusion Injury: Identification of Underlying Gene Expression Changes.High Glucose Impairs Insulin Signaling in the Glomerulus: An In Vitro and Ex Vivo ApproachFasting and Systemic Insulin Signaling Regulate Phosphorylation of Brain Proteins That Modulate Cell Morphology and Link to Neurological Disorders.Cystathionine-γ lyase-derived hydrogen sulfide mediates the cardiovascular protective effects of moxonidine in diabetic ratsHigh-fat diet induces protein kinase A and G-protein receptor kinase phosphorylation of β2 -adrenergic receptor and impairs cardiac adrenergic reserve in animal hearts.Vitamins and their derivatives in the prevention and treatment of metabolic syndrome diseases (diabetes).IRS proteins and diabetic complications.Recent advances of adapter proteins in the regulation of heart diseases.Astrocyte Resilience to Oxidative Stress Induced by Insulin-like Growth Factor I (IGF-I) Involves Preserved AKT (Protein Kinase B) Activity.Metabolic Reprogramming via PPARα Signaling in Cardiac Hypertrophy and Failure From Metabolomics to Epigenetics.Coumarins as potential antidiabetic agents.Effects of long-term resveratrol-induced SIRT1 activation on insulin and apoptotic signalling in aged skeletal muscle.Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizations.Novel mechanism of blood pressure regulation by forkhead box class O1-mediated transcriptional control of hepatic angiotensinogen.Inhibiting Insulin-Mediated β2-Adrenergic Receptor Activation Prevents Diabetes-Associated Cardiac Dysfunction.Mitochondria Associated MicroRNA Expression Profiling of Heart Failure.Development and Characterization of a Novel Congenic Rat Strain for Obesity and Cancer Research.Cardiac Development and Transcription Factors: Insulin Signalling, Insulin Resistance, and Intrauterine Nutritional Programming of Cardiovascular Disease.Polyphenols from Lonicera caerulea L. berry attenuate experimental nonalcoholic steatohepatitis by inhibiting proinflammatory cytokines productions and lipid peroxidation.Effects of neonatal dexamethasone administration on cardiac recovery ability under ischemia-reperfusion in 24-wk-old rats.Bioinformatic screening for key miRNAs and genes associated with myocardial infarction.Opening of mitoKATP improves cardiac function and inhibits apoptosis via the AKT-Foxo1 signaling pathway in diabetic cardiomyopathy
P2860
Q26744743-7E189F30-9074-46E7-B033-D6FA557074A9Q26745026-3C776211-943D-491A-9B1C-B63414E4B5A0Q26782516-0179A996-F708-43A2-AC12-3FB49F777192Q26801165-4AFD2490-30EE-4C32-80DC-481D825E5913Q26822399-D8C88D91-ECB5-43D8-A8CF-9BEF8B8745E7Q28468578-88B2C05A-9776-4B93-AE73-286ED3A6AC4BQ28603117-DA4EF2F1-5D62-4B86-8100-A07B3BBAF41AQ30377910-DED4E105-F678-46A9-917D-19B058CD0C69Q33684174-12AF0FF1-6061-4ACF-BA89-7FC4875B95A1Q33705250-64F05376-2E19-43F2-AEF0-71A7EF1A9372Q33797567-166E3BB9-D912-42CE-93EB-16881FA4577AQ33865096-3771687B-B763-4949-B706-A632FADDDA77Q35851658-06138C28-2668-4B3E-929C-F30373F2D7A1Q36081651-103A6375-C2F1-45A9-869A-F042C0107137Q36444140-5EA372B0-A938-4917-9E22-E99665816F76Q36971492-BC2D5E20-1FCD-481B-B892-2D4A46C3DB78Q37700020-2202FD60-3A95-4B0D-920B-0F085099E53FQ38451830-503B2E03-B2FE-401C-88DB-D70365359BAAQ38924963-87A2FFF7-4F9C-4837-8463-BF69A9A79D8FQ38953404-4580A8B1-657B-4207-AE96-53557CD91E74Q39284593-2D49B46E-2D22-4467-8D08-12907F799037Q39395315-DCC22355-3972-4734-86DC-13BAB16F202FQ39413318-F56D6750-96B8-4EB9-8D9A-61E34F14C60AQ40955525-F353564B-154D-4772-AEA2-E16E1F0CCAB6Q41140714-928A2653-139C-4437-8BCB-074E1885BDD1Q41862140-4F0C4B65-D81E-4DDA-A4A2-5605B25FD155Q46138106-C4392A20-1847-43E2-8A30-00A5DC0D9546Q47152797-248E1077-2C17-4271-97F6-A48162D4C379Q48290155-8D6AFB62-D54B-4AC5-A6CF-8AD0C6798F74Q50290643-3B1D69AC-FAF5-48CE-B4B0-52F2F7E45CC6Q51276812-EB60A8AA-81A7-4F8C-85C8-E8608541146BQ55026578-A7FB1992-CDDF-4E2F-B5EB-0FD7BA86B301Q55383851-DA00373D-7E6B-46DB-BDA6-4DEA67B519EBQ58724803-1F3830A3-BE8E-45B4-8BC9-773480D33A96
P2860
Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38α MAPK during insulin resistance.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Myocardial loss of IRS1 and IR ...... APK during insulin resistance.
@ast
Myocardial loss of IRS1 and IR ...... APK during insulin resistance.
@en
Myocardial loss of IRS1 and IR ...... APK during insulin resistance.
@nl
type
label
Myocardial loss of IRS1 and IR ...... APK during insulin resistance.
@ast
Myocardial loss of IRS1 and IR ...... APK during insulin resistance.
@en
Myocardial loss of IRS1 and IR ...... APK during insulin resistance.
@nl
prefLabel
Myocardial loss of IRS1 and IR ...... APK during insulin resistance.
@ast
Myocardial loss of IRS1 and IR ...... APK during insulin resistance.
@en
Myocardial loss of IRS1 and IR ...... APK during insulin resistance.
@nl
P2093
P2860
P356
P1433
P1476
Myocardial loss of IRS1 and IR ...... APK during insulin resistance.
@en
P2093
Candice Thomas
David E Dostal
Kenneth M Baker
Morris F White
Qinglei Zhu
Shaodong Guo
P2860
P304
P356
10.2337/DB13-0095
P407
P50
P577
2013-11-01T00:00:00Z